Cargando…

Prospective Comprehensive Genomic Profiling of Primary and Metastatic Prostate Tumors

PURPOSE: Comprehensive genomic profiling (CGP) is increasingly used for routine clinical management of prostate cancer. To inform targeted treatment strategies, 3,476 clinically advanced prostate tumors were analyzed by CGP for genomic alterations (GAs) and signatures of genomic instability. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chung, Jon H., Dewal, Ninad, Sokol, Ethan, Mathew, Paul, Whitehead, Robert, Millis, Sherri Z., Frampton, Garrett M., Bratslavsky, Gennady, Pal, Sumanta K., Lee, Richard J., Necchi, Andrea, Gregg, Jeffrey P., Lara, Primo, Antonarakis, Emmanuel S., Miller, Vincent A., Ross, Jeffrey S., Ali, Siraj M., Agarwal, Neeraj
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Clinical Oncology 2019
Materias:	Original Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6583915/ https://www.ncbi.nlm.nih.gov/pubmed/31218271 http://dx.doi.org/10.1200/PO.18.00283

Ejemplares similares

Pan-Cancer Analysis of BRCA1 and BRCA2 Genomic Alterations and Their Association With Genomic Instability as Measured by Genome-Wide Loss of Heterozygosity
por: Sokol, Ethan S., et al.
Publicado: (2020)

Advanced Squamous Cell Carcinomas of the Pelvic and Perineal Region: A Comprehensive Genomic Profiling Study
por: Necchi, Andrea, et al.
Publicado: (2022)

PARP Inhibitor Insensitivity to BRCA1/2 Monoallelic Mutations in Microsatellite Instability-High Cancers
por: Sokol, Ethan S., et al.
Publicado: (2022)

Comprehensive Landscape of Cyclin Pathway Gene Alterations and Co-occurrence with FGF/FGFR Aberrations Across Urinary Tract Tumors
por: Jardim, Denis L F, et al.
Publicado: (2022)

Cyclin Pathway Genomic Alterations Across 190,247 Solid Tumors: Leveraging Large‐Scale Data to Inform Therapeutic Directions
por: Jardim, Denis L., et al.
Publicado: (2020)

Landscape of Cyclin Pathway Genomic Alterations Across 5,356 Prostate Cancers: Implications for Targeted Therapeutics
por: Jardim, Denis L., et al.
Publicado: (2021)

Clinically Advanced Pheochromocytomas and Paragangliomas: A Comprehensive Genomic Profiling Study
por: Bratslavsky, Gennady, et al.
Publicado: (2021)

Phosphatidylinositol 3‐kinase pathway genomic alterations in 60,991 diverse solid tumors informs targeted therapy opportunities
por: Millis, Sherri Z., et al.
Publicado: (2018)

Comparative Genomic Landscape of Urothelial Carcinoma of the Bladder Among Patients of East and South Asian Genomic Ancestry
por: Peak, Taylor, et al.
Publicado: (2023)

Recurrent secondary genomic alterations in desmoplastic small round cell tumors
por: Chow, Warren A., et al.
Publicado: (2020)

The Pan‐Cancer Landscape of Coamplification of the Tyrosine Kinases KIT, KDR, and PDGFRA
por: Disel, Umut, et al.
Publicado: (2019)

Exceptional Response to Everolimus in a Patient with Metastatic Castrate-Resistant Prostate Cancer Harboring a PTEN Inactivating Mutation
por: Kmak, Jamie A., et al.
Publicado: (2020)

Targeting Endoglin to Treat Metastatic Renal Cell Carcinoma: Lessons from Osler‐Weber‐Rendu Syndrome
por: Hahn, Andrew W., et al.
Publicado: (2018)

Comprehensive Genomic Profiling of NF2-Mutated Kidney Tumors Reveals Potential Targets for Therapy
por: Hacking, Sean M, et al.
Publicado: (2023)

Prevalence of established and emerging biomarkers of immune checkpoint inhibitor response in advanced hepatocellular carcinoma
por: Ang, Celina, et al.
Publicado: (2019)

Allelic Selection of Amplicons in Glioblastoma Revealed by Combining Somatic and Germline Analysis
por: LaFramboise, Thomas, et al.
Publicado: (2010)

Comprehensive genomic profiling identifies novel NTRK fusions in neuroendocrine tumors
por: Sigal, Darren S., et al.
Publicado: (2018)

Genomic profiling of solid tumors harboring BRD4-NUT and response to immune checkpoint inhibitors
por: Riess, Jonathan W., et al.
Publicado: (2021)

Decreasing the indications for radical nephrectomy: a study of multifocal renal cell carcinoma
por: Sorbellini, Maximiliano, et al.
Publicado: (2012)

Clustered 8-Oxo-Guanine Mutations and Oncogenic Gene Fusions in Microsatellite-Unstable Colorectal Cancer
por: Madison, Russell W., et al.
Publicado: (2022)

Tissue and liquid biopsy profiling reveal convergent tumor evolution and therapy evasion in breast cancer
por: Sivakumar, Smruthy, et al.
Publicado: (2022)

Primary urethral carcinoma: A Surveillance, Epidemiology, and End Results data analysis identifying predictors of cancer-specific survival
por: Aleksic, Ilija, et al.
Publicado: (2018)

The clinical utility of testicular cancer risk loci
por: Kratz, Christian P, et al.
Publicado: (2011)

Surgical Insights for the Management of Variant Histology in Renal Cell Carcinoma
por: Dispagna, Mauro Antonio, et al.
Publicado: (2021)

Transrectal Ultrasound in Prostate Cancer: Current Utilization, Integration with mpMRI, HIFU and Other Emerging Applications
por: Panzone, John, et al.
Publicado: (2022)

Applications of Focused Ultrasound in the Treatment of Genitourinary Cancers
por: Panzone, John, et al.
Publicado: (2022)

The Current Role of Lymph Node Dissection in Nonmetastatic Localized Renal Cell Carcinoma
por: Ngai, Megan, et al.
Publicado: (2023)

Comparing two assays for clinical genomic profiling: the devil is in the data
por: Squillace, Rachel M, et al.
Publicado: (2015)

Unique Spectrum of Activating BRAF Alterations in Prostate Cancer
por: Chehrazi-Raffle, Alex, et al.
Publicado: (2023)

Sixth BHD Symposium and First International Upstate Kidney Cancer Symposium: latest scientific and clinical discoveries
por: Bratslavsky, Gennady, et al.
Publicado: (2016)

Comprehensive characterization of RAS mutations in colon and rectal cancers in old and young patients
por: Serebriiskii, Ilya G., et al.
Publicado: (2019)

The genomic landscape of metastatic breast cancer: Insights from 11,000 tumors
por: Rinaldi, Jacob, et al.
Publicado: (2020)

Molecular Profiling of Refractory Adrenocortical Cancers and Predictive Biomarkers to Therapy
por: Millis, Sherri Z., et al.
Publicado: (2015)

An Unusual Etiology of Urinary Retention – Small Cell Prostate Carcinoma
por: Li, Guanqun, et al.
Publicado: (2016)

Structure and Function of the Nuclear Receptor Superfamily and Current Targeted Therapies of Prostate Cancer
por: Porter, Baylee A., et al.
Publicado: (2019)

Comprehensive pan-cancer genomic landscape of KRAS altered cancers and real-world outcomes in solid tumors
por: Lee, Jessica K., et al.
Publicado: (2022)

Correlation of genomic alterations assessed by next-generation sequencing (NGS) of tumor tissue DNA and circulating tumor DNA (ctDNA) in metastatic renal cell carcinoma (mRCC): potential clinical implications
por: Hahn, Andrew W., et al.
Publicado: (2017)

Sporadic renal angiomyolipoma in a patient with Birt-Hogg-Dubé: chaperones in pathogenesis
por: Sager, Rebecca A., et al.
Publicado: (2018)

MHC-I genotype and tumor mutational burden predict response to immunotherapy
por: Goodman, Aaron M., et al.
Publicado: (2020)

Clinical and analytical validation of FoundationOne(®)CDx, a comprehensive genomic profiling assay for solid tumors
por: Milbury, Coren A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_okgtd1s3vb4sodhkbma3lkrmo4